MLchartDataset catalogue

MEPACT

Term · Oncology and biomedicine · MLC-T-ONC-005273

A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. MEPACT activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called L-MTP-PE, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.

Table 1. Record
IdentifierMLC-T-ONC-005273
FieldOncology and biomedicine
Expansionsmifamurtide; muramyl tripeptide phosphatidylethanolamine
SynonymsL-MTP-PE
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005273",
  "term": "MEPACT",
  "field": "Oncology and biomedicine",
  "definition": "A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. MEPACT activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called L-MTP-PE, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.",
  "expansions": [
    "mifamurtide",
    "muramyl tripeptide phosphatidylethanolamine"
  ],
  "synonyms": [
    "L-MTP-PE"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/mepact/"
}

Record 10,858 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.